SCP Vitalife Partners is a private equity general partner firm with offices in Israel and United States.
Regentis Biomaterials, a developer of cartilage repair solutions, closed a $15m Series D funding from SCP Vitalife Partners and others.
Invenix, which is developing an infusion management system for hospitals, has secured $42m in funding from SCP Vitalife Partners and others.
MST – Medical Surgery Technologies, an Israel-based developer of image-guided surgical systems, closed a $12.5m Series C funding.
Read more news concerning SCP Vitalife Partners
A sampling of SCP Vitalife Partners portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?